Phase 1/2 × Completed × Central Nervous System Neoplasms × Clear all A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Phase 1/2 Completed
29 enrolled
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Phase 1/2 Completed
116 enrolled 31 charts
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Phase 1/2 Completed
76 enrolled 25 charts
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Phase 1/2 Completed
64 enrolled 29 charts
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Phase 1/2 Completed
12 enrolled 11 charts
MSC11FCD-GBM
Phase 1/2 Completed
10 enrolled
RTOG 0913
Phase 1/2 Completed
279 enrolled 14 charts
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
Phase 1/2 Completed
96 enrolled 19 charts
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
Phase 1/2 Completed
40 enrolled 32 charts
Sirolimus in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
13 enrolled
DEND/TIA
Phase 1/2 Completed
6 enrolled
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1/2 Completed
122 enrolled 11 charts
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
217 enrolled 12 charts
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
92 enrolled 18 charts
Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1/2 Completed
35 enrolled 13 charts
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Phase 1/2 Completed
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
Phase 1/2 Completed
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Phase 1/2 Completed
105 enrolled
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 1/2 Completed
136 enrolled
CCI-779 in Treating Patients With Malignant Glioma
Phase 1/2 Completed
49 enrolled
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase 1/2 Completed
60 enrolled 10 charts
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Phase 1/2 Completed
257 enrolled 16 charts
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
58 enrolled
Study of D-Methadone in Patients With Chronic Pain
Phase 1/2 Completed
10 enrolled 6 charts
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
Phase 1/2 Completed
26 enrolled 7 charts
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
Phase 1/2 Completed
19 enrolled
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
Phase 1/2 Completed
61 enrolled 8 charts
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
40 enrolled
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Phase 1/2 Completed
84 enrolled
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Phase 1/2 Completed
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Phase 1/2 Completed
Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1/2 Completed
24 enrolled
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
Phase 1/2 Completed
EMD 121974 in Treating Patients With Progressive or Recurrent Glioma
Phase 1/2 Completed
Immunotoxin Therapy in Treating Patients With Malignant Glioma
Phase 1/2 Completed
Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
Phase 1/2 Completed
Irinotecan in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
Procarbazine in Treating Patients With Recurrent Brain Tumor
Phase 1/2 Completed
COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
Phase 1/2 Completed
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
Phase 1/2 Completed
48 enrolled
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Phase 1/2 Completed
30 enrolled
AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
Phase 1/2 Completed
16 enrolled
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Phase 1/2 Completed
10 enrolled
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
Phase 1/2 Completed
47 enrolled
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
20 enrolled
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
82 enrolled